… To assess the effectiveness of the HPV vaccines in preventing genital warts (GW) in women
aged 14–23 years and to estimate the incidence of GW in the whole population aged from …

… human papillomavirus (HPV) vaccine has been assumed to give protection against genital
warts (GW) as well as cervical cancer. Our main question was whether HPV vaccine has any …

… of HPV vaccine in preventing the relapse of ano-genital warts. The results suggest that HPV
vaccination does not provide secondary benefit in patients with previous ano-genital warts. …

… genital warts after primary carbon dioxide laser treatment before the introduction of the
vaccination against HPV. … recurrence rates of genital warts before HPV vaccination and underline …

… . Rapid decline in presentations of genital warts after the implementation of a national
quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect …

… decreasing HPV infection and related diseases, such as warts … about current HPV vaccines,
focusing on vaccine coverage … genital warts caused by the HPV types covered by Gardasil [9,…

… HPV-related disease. We provide nationwide, real-world data on the risk of genital warts (GWs)
after <3 vaccine … against GWs with the quadrivalent HPV vaccine (HPV types 6, 11, 16, …

… This systematic review shows that the incidence of GWs in women depends on the age of
vaccination and the number of doses of HPV vaccine administered. The incidence rate of GWs …

… of a nonavalent HPV vaccination for treatment of genital warts because the vaccine may
be beneficial as an alternative noninvasive treatment of recalcitrant genital warts. However, …

… To evaluate the treatment effect of genital warts, we investigated the quadrivalent HPV
vaccine … Our results suggested that HPV vaccines could be effective in management of genital …